Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of dota-psma-eb-01 in China, also supports custom service. Welcome to wholesale bulk high quality dota-psma-eb-01 from our factory. Contact us for more details.
| Description | DOTA-PSMA-EB-01 (compound LNC1003) is a multifunctional radioligand precursor integrating a DOTA macrocyclic chelator, a PSMA (prostate-specific membrane antigen) inhibitor pharmacophore, and an Evans blue (EB) albumin-binding domain. PSMA is a type II transmembrane glycoprotein highly expressed on prostate cancer cell surfaces and an ideal target for prostate cancer imaging and therapy. The Evans blue domain reversibly binds serum albumin, significantly prolonging the blood circulation half-life of the ligand and thereby enhancing tumor uptake and retention. Preclinical studies demonstrate that DOTA-PSMA-EB-01 has a PSMA IC₅₀ of 10.77 nM with high specific inhibitory activity; ¹⁷⁷Lu-labeled compound significantly enhances radionuclide uptake and retention in tumors, demonstrating excellent targeted radionuclide therapy efficacy in prostate cancer models. The DOTA chelator can be labeled with ⁶⁸Ga (PET imaging), ¹⁷⁷Lu/⁹⁰Y (therapy), and other radionuclides, enabling prostate cancer theranostics. |
| Peptide purity (HPLC) | ≥95% |
| Molecular formula | C₈₇H₁₁₅N₁₅O₂₈S₂ |
| Molecular weight (Da) | 1883.06 Da |
| Structure type | Type Multifunctional conjugate (DOTA + PSMA inhibitor + Evans blue albumin-binding domain) |
| Solubility | Freely soluble in DMSO, DMF; soluble in water (pH 7-8) |
| Storage | -20°C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| DOTA-PSMA-EB-01 | DOTA-PSMA binding peptide EB-01; prostate cancer theranostic peptide | Prostate cancer targeted theranostics, PSMA specific binding, PET imaging / radiotherapy | DOTA macrocyclic chelator conjugated with high-affinity PSMA inhibitor peptide EB-01; peptide specifically binds prostate-specific membrane antigen (PSMA); DOTA chelates radionuclides for imaging or therapy | C₆₈H₉₈N₁₆O₁₈ | 1482.72 | ~1483.8 | Acetate | 10 (10-mer + DOTA) |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-DPS001 | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. Soluble in dilute acetic acid, PBS and normal saline. Macrocyclic chelating group readily binds transition metal ions. Avoid combination with high-concentration metal salts. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-DPS001 | DOTA-PSMA-EB-01 binds PSMA with high affinity for prostate cancer imaging & therapy | DOTA-PSMA-EB-01 is a bifunctional theranostic peptide for prostate cancer. The EB-01 peptide moiety is a high-affinity PSMA inhibitor that specifically binds prostate-specific membrane antigen (PSMA) overexpressed on prostate cancer cells. The N-terminal DOTA macrocycle chelates ⁶⁸Ga / ¹⁸F for PET diagnostic imaging, or ¹⁷⁷Lu / ²²⁵Ac for targeted radiotherapy, enabling integrated diagnosis and therapy of prostate cancer. | Prostate cancer theranostics, PSMA targeting research, nuclear medicine imaging, targeted radiotherapy, tumor theranostics | Prostate-specific membrane antigen (PSMA); DOTA metal chelation site; enzyme inhibition + receptor-mediated endocytosis |
Hot Tags: dota-psma-eb-01, China dota-psma-eb-01 manufacturers, suppliers, factory, 997-20-6, CAS 203716 10 3, drug delivery peptides, MPG Peptide, NGR peptide, Transportan
